205 related articles for article (PubMed ID: 25589316)
1. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
[TBL] [Abstract][Full Text] [Related]
2. [EFFICACY OF CYTOFLAVIN IN COMPLEX TREATMENT OF DIABETIC FOOT SYNDROME].
Skrypko V; Kovalenko A; Zaplutanov V; Kharitonova T; Myhaloyko I
Georgian Med News; 2017 Apr; (265):14-19. PubMed ID: 28574379
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the Cytoflavin on the distal polyneuropathy severity in patients with diabetic foot syndrome with arteries mediacalcinosis].
Skripko VD; Kovalenko AL; Zaplutanov VA
Khirurgiia (Mosk); 2017; (8):75-78. PubMed ID: 28805783
[TBL] [Abstract][Full Text] [Related]
4. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
6. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
7. [Cytoflavin rationale for the use in treatment of patients with postsurgical hypothyroidism].
Skripkо VD; Pasko AJ; Kovalenko AL; Zaplutanov VA
Khirurgiia (Mosk); 2016; (7):53-57. PubMed ID: 27459489
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
[TBL] [Abstract][Full Text] [Related]
9. [Cytoflavin in the treatment of patients with chronic abacterial prostatitis and erectile dysfunction].
Churakov AA; Kolesnikov AI; Bliumberg BI; Popkov VM
Urologiia; 2012; (5):64-6, 68. PubMed ID: 23342619
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].
Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759
[TBL] [Abstract][Full Text] [Related]
11. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy].
Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN
Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
[No Abstract] [Full Text] [Related]
13. [The application of combined physiotherapeutic methods for the complex treatment of patients with dyscirculatory encephalopathy].
Shiman AG; Klocheva EG; Kaiumov SF; Shoferova SD; Zhukova MV
Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (2):9-12. PubMed ID: 22908466
[TBL] [Abstract][Full Text] [Related]
14. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
[TBL] [Abstract][Full Text] [Related]
17. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
[TBL] [Abstract][Full Text] [Related]
18. [Modern methods of energy homeostasis correction in elderly patients].
Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
[TBL] [Abstract][Full Text] [Related]
19. [Features of psychopharmacotherapeutic correction of alcohol dependence in the elderly].
Belov VG; Parfenov IuA; Zaplutanov VA
Adv Gerontol; 2013; 26(4):702-6. PubMed ID: 24738263
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy].
Pochepen' ON
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
